menu
    • menu

    Company profile for Alto Neuroscience

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    To bring every person suffering from a mental health condition the right treatment for them, right away. Alto Neuroscience is a clinical-stage biopharmaceutical company that integrates the biology of the patient into drug development to improve the lives of people with mental health conditions. Through our AI-enabled biomarker platform, we combine rich sources of information on patients’ brain activity and behavior to rapid...
    To bring every person suffering from a mental health condition the right treatment for them, right away. Alto Neuroscience is a clinical-stage biopharmaceutical company that integrates the biology of the patient into drug development to improve the lives of people with mental health conditions. Through our AI-enabled biomarker platform, we combine rich sources of information on patients’ brain activity and behavior to rapidly develop highly-effective medicines for targeted populations. We aim to replace today's trial-and-error clinical approach by aligning the right Alto drug with the right patient

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Alto NeuroscienceUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    369 South San Antonio Road Los Altos, CA 94022
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.altoneuroscience.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/altoneuroscience/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alto Neuroscience: New Inducement Stock Grants Under NYSE Rule
    Alto Neuroscience: New Inducement Stock Grants Under NYSE Rule

    03 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251203087055/en/Alto-Neuroscience-Announces-New-Employee-Inducement-Grants-Under-NYSE-Rule-303A.08

    BUSINESSWIRE
    03 Dec 2025
    Share Share
    Alto Neuroscience Reveals Q3 2025 Financials & Business Updates
    Alto Neuroscience Reveals Q3 2025 Financials & Business Updates

    12 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251112497891/en/Alto-Neuroscience-Reports-Third-Quarter-2025-Financial-Results-and-Recent-Business-Highlights

    BUSINESSWIRE
    12 Nov 2025
    Share Share
    Alto Neuroscience To Participate In Upcoming Investor Conferences
    Alto Neuroscience To Participate In Upcoming Investor Conferences

    28 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251028146760/en/Alto-Neuroscience-to-Participate-in-Upcoming-Investor-Conferences

    BUSINESSWIRE
    28 Oct 2025
    Share Share
    Alto Neuroscience Reveals $50M Private Placement Financing
    Alto Neuroscience Reveals $50M Private Placement Financing

    20 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251020503608/en/Alto-Neuroscience-Announces-%2450-Million-Private-Placement-Financing

    BUSINESSWIRE
    20 Oct 2025
    Share Share
    Alto Neuro to Advance ALTO-207 for Treatment-Resistant Depression
    Alto Neuro to Advance ALTO-207 for Treatment-Resistant Depression

    20 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251020895285/en/Alto-Neuroscience-Announces-Plans-to-Accelerate-Development-of-ALTO-207-in-Treatment-Resistant-Depression-Following-Successful-Outcome-from-Recent-FDA-Meeting

    BUSINESSWIRE
    20 Oct 2025
    Share Share
    Alto Neuro's ALTO-101 Granted FDA Fast Track Designation
    Alto Neuro's ALTO-101 Granted FDA Fast Track Designation

    03 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251003096029/en/Alto-Neuroscience-Receives-FDA-Fast-Track-Designation-for-ALTO-101-for-the-Treatment-of-Cognitive-Impairment-Associated-with-Schizophrenia

    BUSINESSWIRE
    03 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search